The Heart Center of Indiana

Held, Shan
January 2006
Indiana Business Magazine;Jan2006, Vol. 50 Issue 1, p39
The article discusses the accomplishments of The Heart Center of Indiana (THCI), the first freestanding hospital in Indianapolis, Indiana. As reported by the HealthGrades Inc., an independent provider of hospital ratings, THCI ranked number one last October 2005 for overall cardiac services. The center also received the highest rating in treatment of heart attack and cardiac interventions categories.


Related Articles

  • COOL DOWN AFTER CARDIAC ARREST. Harrar, Sari; J.M. // Prevention;Aug2002, Vol. 54 Issue 8, p144 

    Reports that cooling down cardiac-arrest patients once they reach the hospital can almost double their chances of making it out of the hospital and reduces brain damage significantly.

  • The 123s and ABCs of the simplified SYNTAX score. Bing, R.; Zhao, J.; Papapostolou, S.; Burgess, S.; Danson, E.; Bhindi, R.; Lo, S.; Chan, W.; Ng, M.; Kritharides, L.; Yong, A. // Heart, Lung & Circulation;2015 Supplement 3, Vol. 24, pS306 

    No abstract available.

  • The Debate in Cuba's Scientific Community on Sudden Cardiac Death. Vilches, Ernesto; Ochoa, Luis A.; Ramos, Lianne // MEDICC Review;Oct2015, Vol. 17 Issue 4, p48 

    Sudden cardiac death poses a challenge to modern medicine because of its high incidence, the unexpected and dramatic nature of the event, and years of potential life lost. What’s more, despite modest decreases in global mortality attributed to cardiovascular diseases, incidence of sudden...

  • Help for Failing Hearts.  // Medical Update;2005, Vol. 30 Issue 10, p5 

    Focuses on the results of a medical study which evaluated the efficiency of external counterpulsation therapy in preventing and treating heart diseases in U.S. patients in April 2005. Advantages of the treatment over drug therapy; Assessment of the effect of the therapy on patients with...

  • Antioxidant treatment for heart failure: friend or foe? M. J. Thomson; M. P. Frenneaux; J. C. Kaski // QJM: An International Journal of Medicine;May2009, Vol. 102 Issue 5, p305 

    Increasing studies demonstrate a pivotal role for oxidant stress in the pathophysiology of heart failure (HF). Recent meta-analyses also reveal the potential pitfall of a mono-dimensional antioxidant approach. This review article summarizes the main biological pathways involved in oxidant stress...

  • Use, tolerability and compliance of spironolactone in the treatment of heart failure. Lachaine, Jean; Beauchemin, Catherine; Ramos, Elodie // BMC Clinical Pharmacology;2011, Vol. 11 Issue 1, p4 

    Background: Risk of morbidity and mortality in patients with severe heart failure (HF) is reduced by blockade of aldosterone receptors with spironolactone. However, benefits of spironolactone are potentially limited by treatment compliance and adverse events profile. The aim of this study was to...

  • Levosimendan in the treatment of AHF: lessons from surveys and clinical trials. Mebazaa, Alexandre; Delgado, Juan F.; Franco, Fatima; Toller, Wolfgang; Parissis, John; Pini, Daniela; Giannakoulas, George; Gorjup, Vojka; Karpati, Peter C.J.; Follath, Ferenc; Nieminen, Markku S. // European Journal of Heart Failure. Supplements;Jun2008, Vol. 7 Issue 2, p228 

    Abstract: Acute heart failure (AHF) is a primary cause of hospital admission throughout the world. Several acute heart failure registries have been conducted in the United States (U.S.) and Europe assessing the clinical presentation of AHF in the real world. Of the five large registries two were...

  • Levosimendan: a decade of experience in Europe built on years of evidence. Parissis, John; Toller, Wolfgang; Franco, Fatima; Delgado, Juan F.; Danou, Fotini; Llorens-Soriano, Pere; Karpati, Peter C.J.; Nieminen, Markku S.; Mebazaa, Alexandre; Follath, Ferenc // European Journal of Heart Failure. Supplements;Jun2008, Vol. 7 Issue 2, p234 

    Abstract: Recent European Society of Cardiology''s (ESC) guidelines on the diagnosis and treatment of acute heart failure (AHF), suggest that an essential target in the management of these patients is to improve symptoms within hours, which should persist until hospital release, also protecting...

  • The short QT syndrome. Cross, Brian; Homoud, Munther; Link, Mark; Foote, Caroline; Garlitski, Ann C.; Weinstock, Jonathan; Estes III, N. A. Mark // Journal of Interventional Cardiac Electrophysiology;Jun2011, Vol. 31 Issue 1, p25 

    The article discusses research on the historical features and insights into the short QT syndrome (SQTS). It analyzes the results of several electrocardiographic (ECG) findings and exercise electrocardiographic studies in SQTS patients. SQTS is a hereditary channelopathy characterized by the...


Read the Article


Sign out of this library

Other Topics